Hamel Associates, Inc. Novartis Ag Transaction History
Hamel Associates, Inc.
- $315 Million
- Q2 2024
A detailed history of Hamel Associates, Inc. transactions in Novartis Ag stock. As of the latest transaction made, Hamel Associates, Inc. holds 8,645 shares of NVS stock, worth $1.02 Million. This represents 0.29% of its overall portfolio holdings.
Number of Shares
8,645
Previous 8,645
-0.0%
Holding current value
$1.02 Million
Previous $836,000
10.05%
% of portfolio
0.29%
Previous 0.27%
Shares
23 transactions
Others Institutions Holding NVS
# of Institutions
1,421Shares Held
138MCall Options Held
1.48MPut Options Held
1.54M-
Dodge & Cox San Francisco, CA12.2MShares$1.44 Billion0.82% of portfolio
-
Primecap Management CO Pasadena, CA12.2MShares$1.43 Billion0.95% of portfolio
-
Morgan Stanley New York, NY7.42MShares$872 Million0.06% of portfolio
-
Dimensional Fund Advisors LP Austin, TX7.41MShares$871 Million0.21% of portfolio
-
Loomis Sayles & CO L P5.95MShares$699 Million0.87% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $253B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...